Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 19,342 | 14,953 | 13,304 | 16,739 | 14,719 |
| Operating Income | -19,342 | -14,953 | -13,304 | -16,739 | -14,719 |
| Other Income | -1,215 | 1,397 | 188 | 561 | -114 |
| Pre-tax Income | -20,557 | -13,556 | -13,116 | -16,178 | -14,833 |
| Income Tax | 76 | N/A | 72 | N/A | 0 |
| Net Income Continuous | -20,633 | -13,556 | -13,188 | -16,178 | -14,833 |
| Minority Interests | N/A | -58 | -92 | -99 | -48 |
| Net Income | $-20,882 | $-13,499 | $-13,096 | $-16,080 | $-14,785 |
| EPS Basic Total Ops | -0.45 | -0.34 | -0.34 | -0.41 | -0.37 |
| EPS Basic Continuous Ops | -0.45 | -0.35 | -0.34 | -0.42 | -0.39 |
| EPS Diluted Total Ops | -0.45 | -0.34 | -0.34 | -0.41 | -0.37 |
| EPS Diluted Continuous Ops | -0.45 | -0.35 | -0.34 | -0.42 | -0.39 |
| EBITDA(a) | $-18,760 | $-14,403 | $-12,730 | $-16,148 | $-14,390 |